[1]
2024. Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s467. DOI:https://doi.org/10.25251/skin.8.supp.467.